Ledger.Open graph →
SEC Form D · filed August 14, 2023

Inflammasome Therapeutics, Inc

Offering
$3.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
NEWTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Paul Ashton · Newton, MAExec · DirectorJayakrishna Ambati · Newton, MADirectorJoon Lee · Newton, MADirectorMary Weber · Newton, MADirectorBalamurali Ambati · Newton, MADirectorNapoleone Ferrara · Newton, MADirectorJayakrishna Ambati · Newton, MADirectorJoon Lee · Newton, MADirectorNapoleone Ferrara · Newton, MADirectorMary Weber · Newton, MADirectorBalamurali Ambati · Newton, MADirectorPaul Ashton · Newton, MAExec · DirectorAdam Kall · Marquette, MIDirectorAustin Morris · Marquette, MIExec · DirectorStephen Zimba · EUGENE, ORDirectorKenneth Epps · EUGENE, ORDirectorMichele Zimba · EUGENE, ORDirectorJames Shephard · EUGENE, ORDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗